| [1] |
Chugh SS，Havmoeller R，Narayanan K，et al.Worldwide epidemiology of atrial fibrillation：a Global Burden of Disease 2010 Study[J].Circulation，2014，129（8）：837-847.
|
| [2] |
周自强，胡大一，陈捷，等.中国心房颤动现状的流行病学研究[J].中华内科杂志，2004（7）：15-18.
|
| [3] |
Ball J，Carrington MJ，Mcmurray JJ，et al.Atrial fibrillation：profile and burden of an evolving epidemic in the 21stcentury[J].Int JCardiol，2013，167（5）：1807-1824.
|
| [4] |
Wang TJ，Larson MG，Levy D，et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality：the Framingham Heart Study[J].Circulation，2003，107（23）：2920-2925.
|
| [5] |
Wolf PA，Dawber TR，Thomas HJ，et al.Epidemiologic assessment of chronic atrial fibrillation and risk of stroke：the Framingham study[J].Neurology，1978，28（10）：973-977.
|
| [6] |
Andersson T，Magnuson A，Bryngelsson IL，et al.All-cause mortality in 272，186 patients hospitalized with incident atrial fibrillation 1995～2008：a Swedish nationwide long-term case-control study[J].Eur Heart J，2013，34（14）：1061-1067.
|
| [8] |
黄从新，张澍，黄德嘉，等.心房颤动：目前的认识和治疗建议-2015[J].中国心脏起搏与心电生理杂志，2015（5）：377-434.
|
| [10] |
Flegel KM，Shipley MJ，Rose G.Risk of stroke in nonrheumatic atrial fibrillation[J].Lancet，1987，1（8532）：526-529.
|
| [13] |
王春娟，王春雪，王拥军，等.中国非瓣膜性心房颤动患者华法林使用不足的相关因素分析[J].中国新药杂志，2012（11）：1203-1209.
|
| [21] |
赵世华.齐头并进，共谱新篇章:论影像学在结构性心脏病介入治疗中的指导价值[J].中华心血管病杂志，2016，44（10）：830-832.
|
| [7] |
Magnussen C，Niiranen TJ，Ojeda FM，et al.Sex Differences and Similarities in Atrial Fibrillation Epidemiology，Risk Factors，and Mortality in Community Cohorts：ResultsFrom the BiomarCaRE Consortium（Biomarker for Cardiovascular Risk Assessment in Europe）[J].Circulation，2017，136（17）：1588-1597.
|
| [9] |
January CT，Wann LS，Alpert JS，et al.2014 AHA/ACC/HRS guideline for themanagement of patientswith atrial fibrillation：executive summary：a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J].Circulation，2014，130（23）：2071-2104.
|
| [11] |
Pisters R，Lane DA，NieuwlaatR，etal.A novel user-friendly score（HAS-BLED）to assess1-year risk ofmajor bleeding in patientswith atrial fibrillation：the Euro Heart Survey[J].Chest，2010，138（5）：1093-1100.
|
| [12] |
Hart RG，Pearce LA，Aguilar MI.Meta-analysis：antithrombotic therapy to prevent stroke in patientswho have nonvalvular atrial fibrillation[J].Ann Intern Med，2007，146（12）：857-867.
|
| [14] |
Ruff CT，Giugliano RP，Braunwald E，et al.Comparison of the efficacy and safety of new oral anticoagulantswith warfarin in patients with atrial fibrillation：ameta-analysis of randomised trials[J].Lancet，2014，383（9921）：955-962.
|
| [15] |
Ntaios G，Papavasileiou V，Makaritsis K，et al.Real-world setting comparison of Nonvitamin-K antagonist oral Anticoagulants versus Vitamin-K antagonists for stroke prevention in atrial fibrillation：a Systematic Review and Meta-Analysis[J].Stroke，2017，48（9）：2494-2503.
|
| [16] |
Cha MJ，Choi EK，Han KD，et al.Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation[J].Stroke，2017，48（11）： 3040-3048.
|
| [17] |
Kirchhof P，Benussi S，Kotecha D，et al.2016 ESC Guidelines for themanagement of atrial fibrillation developed in collaborationwith EACTS[J].Eur JCardiothorac Surg，2016，50（5）：e1-e88.
|
| [18] |
Holmes DR，Reddy VY，Turi ZG，etal.Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention ofstroke in patientswith atrial fibrillation：a randomised non-inferiority trial[J].Lancet，2009，374（9689）：534-542.
|
| [19] |
Reddy VY，Holmes D，Doshi SK，et al.Safety of percutaneous leftatrialappendage closure：results from theWatchman Left Atrial Appendage System for Embolic Protection in Patientswith AF（PROTECT AF）clinical trial and the Continued Access Registry[J].Circulation，2011，123（4）：417-424.
|
| [20] |
Holmes DJ，Kar S，Price MJ，et al.Prospective randomized evaluation of theWatchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy：the PREVAIL trial[J].JAm Coll Cardiol，2014，64（1）：1-12.
|
| [22] |
Reddy VY，Doshi SK，Kar S，et al.5-year outcomes after left atrial appendage closure：From the PREVAIL and PROTECTAFTrials[J].JAm Coll Cardiol，2017，70（24）：2964-2975.
|
| [23] |
Wyse DG，Waldo AL，Dimarco JP，et al.A comparison of rate control and rhythm control in patients with atrial fibrillation[J].N Engl JMed，2002，347（23）：1825-1833.
|
| [24] |
Steinberg JS，Sadaniantz A，Kron J，etal.Analysis of causespecific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management（AFFIRM）study[J].Circulation，2004，109（16）：1973-1980.
|
| [25] |
Hakalahti A，Biancari F，Nielsen JC，et al.Radiofrequency ablation vs.antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation：systematic review and meta-analysis[J].Europace，2015，17（3）：370-378.
|
| [26] |
Haissaguerre M，Jais P，Shah DC，et al.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J].N Engl JMed，1998，339（10）：659-666.
|
| [27] |
Ganesan AN，Shipp NJ，BrooksAG，etal.Long-term Outcomes of Catheter Ablation of Atrial Fibrillation：a Systematic Review and Meta-analysis[J].JAm HeartAssoc，2013，2（2）：e4549.
|
| [28] |
Bunch TJ，Crandall BG，Weiss JP，etal.Patients treated with catheterablation foratrial fibrillationhave long-term ratesof death，stroke，and dementia similar to patientswithout atrial fibrillation[J].JCardiovasc Electrophysiol，2011，22（8）：839-845.
|
| [29] |
Calkins H，Kuck KH，Cappato R，et al.2012 HRS/EHRA/ECASExpert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation：recommendations for patient selection，procedural techniques，patientmanagement and follow-up，definitions，endpoints，and research trial design[J].Europace，2012，14（4）：528-606.
|
